Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWH · Entity 7871 | Interim CFO | November 12, 2024 | November 14, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date November 12, 2024 · Filed November 14, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.84 · Expires 2027-11-12 | Direct | 25,000 |
Reported balance
After 2024-11-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-11-12 · Grant · Acquired 25,000 · Balance 25,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2024 Filed Nov 14, 2024 21:54 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantStock Options (Right to buy) · Derivative | 25,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-24-007697 · primarydocument.xml · derivative · entry 1 Kallassy John A · CIK 0001379818 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-11-12 Read SEC document |
| August 15, 2024 Filed Aug 26, 2024 11:21 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-100343 · ownership.xml · derivative · entry 1 Kallassy John A · CIK 0001379818 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-08-15 F1 · derivative.exercise_date: The stock option will vest in six equal amounts, with 1/6 of the grant vesting upon the grant date and an additional 1/6 vesting each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.